Legacy Financial Advisors Inc. Makes New $213,000 Investment in Colgate-Palmolive (NYSE:CL)

Legacy Financial Advisors Inc. purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 2,199 shares of the company’s stock, valued at approximately $213,000.

Several other institutional investors have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive during the second quarter valued at approximately $25,000. Core Wealth Advisors Inc. raised its position in shares of Colgate-Palmolive by 56.6% during the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares in the last quarter. Rise Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth $38,000. Continuum Advisory LLC grew its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares in the last quarter. Finally, Voisard Asset Management Group Inc. bought a new position in Colgate-Palmolive in the fourth quarter valued at $40,000. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock worth $4,486,063 over the last ninety days. 0.34% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CL has been the subject of a number of research reports. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Sanford C. Bernstein increased their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their target price for the company from $107.00 to $109.00 in a report on Monday, September 9th. Finally, Evercore ISI boosted their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $103.83.

Colgate-Palmolive Stock Up 1.0 %

Shares of Colgate-Palmolive stock opened at $103.06 on Monday. The company’s fifty day simple moving average is $102.71 and its two-hundred day simple moving average is $95.89. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The company has a market cap of $84.55 billion, a P/E ratio of 32.61, a PEG ratio of 3.72 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same quarter in the previous year, the company earned $0.77 earnings per share. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. Research analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is presently 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.